Sodium hyaluronate-g-2-((N-(6-aminohexyl)-4-methoxyphenyl)sulfonamido)-N-hydroxyacetamide with enhanced affinity towards MMP12 catalytic domain to be used as visco-supplement with increased degradation resistance.
Catalytic Domain
Chondrocytes
/ drug effects
Hyaluronic Acid
/ chemical synthesis
Hydroxamic Acids
/ chemical synthesis
Matrix Metalloproteinase 12
/ chemistry
Matrix Metalloproteinase Inhibitors
/ chemical synthesis
Protein Binding
Sulfonamides
/ chemical synthesis
Viscoelastic Substances
/ chemical synthesis
Degradation
Hyaluronic acid
MMP inhibitors
Synovial fluid
Viscosupplementation
Journal
Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156
Informations de publication
Date de publication:
01 Nov 2021
01 Nov 2021
Historique:
received:
03
05
2021
revised:
13
07
2021
accepted:
14
07
2021
entrez:
8
8
2021
pubmed:
9
8
2021
medline:
6
1
2022
Statut:
ppublish
Résumé
The present paper describes the functionalization of sodium hyaluronate (NaHA) with a small molecule (2-((N-(6-aminohexyl)-4-methoxyphenyl)sulfonamido)-N-hydroxyacetamide) (MMPI) having proven inhibitory activity against membrane metalloproteins involved in inflammatory processes (i.e. MMP12). The obtained derivative (HA-MMPI) demonstrated an increased resistance to the in-vitro degradation by hyaluronidase, viscoelastic properties close to those of healthy human synovial fluid, cytocompatibility towards human chondrocytes and nanomolar affinity towards MMP 12. Thus, HA-MMPI can be considered a good candidate as viscosupplement in the treatment of knee osteoarticular disease.
Identifiants
pubmed: 34364546
pii: S0144-8617(21)00839-0
doi: 10.1016/j.carbpol.2021.118452
pii:
doi:
Substances chimiques
Hydroxamic Acids
0
Matrix Metalloproteinase Inhibitors
0
Sulfonamides
0
Viscoelastic Substances
0
Hyaluronic Acid
9004-61-9
Matrix Metalloproteinase 12
EC 3.4.24.65
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
118452Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.